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Abstract
Background: Methicillin-resistant Staphylococcus aureus (MRSA) clones pose a significant threat to hospitalised
patients because the bacteria can be transmitted by asymptomatic carriers within healthcare facilities. To date,
nothing is known about the prevalence of S. aureus and MRSA among healthcare workers in Madagascar.
The objective of our study was to examine the prevalence and clonal epidemiology of nasal S. aureus and MRSA
among healthcare workers and non-medical University students in Antananarivo, Madagascar.
Methods: This cross sectional study screened nasal swabs taken from students and healthcare workers for S. aureus.
Multiplex PCR was performed to identify S. aureus-specific (nuc), MRSA-specific mecA and mecC genes, Panton-
Valentine leukocidin (PVL) (lukF-PV), and toxic shock syndrome toxin-1 (TSST-1) specific genes in methicillin-sensitive
S. aureus (MSSA) and MRSA isolates. Staphylococcus protein A gene (spa) typing was performed for all confirmed
MRSA isolates. The frequency distribution of nasal S. aureus and MRSA of healthcare workers and non-medical
students was compared using Pearson’s χ2 test.
Results: Of 1548 nasal swabs tested, 171 (11 %) were positive for S. aureus; 20 (1.3 %) of these isolates were
identified as MRSA. S. aureus was detected in 91 of 863 healthcare workers (10.4 %) and in 80 (11.8 %) of 685
students; however, 14 (1.5 %) healthcare workers carried MRSA compared with six (0.9 %) students. Nasal carriage of
S. aureus and MRSA was more prevalent in women than in men, and 21 (11.7 %) S. aureus isolates were PVL-
positive and 36 (21 %) were TSST-1 positive. The mecC gene was not detected in any isolates. Five different spa
types were identified, with spa type t186 being the predominant MRSA clone (16/20).
Conclusion: The results of the present study reveal a low frequency of S. aureus and MRSA nasal carriage in both
students and healthcare workers from Antananarivo, Madagascar. The predominant MRSA clone (t186) was
previously described in hospitalised patients in Madagascar.
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Background
The bacterium Staphylococcus aureus causes a variety of
infections, ranging from skin and soft tissue infections
to life-threatening disease [1]. It is also a commensal
that colonises the anterior nares of asymptomatic car-
riers, who may unknowingly transmit the pathogen
within the community or within healthcare facilities [2].
Carriage among healthcare workers (HCW) may act as a
source of infection in hospitals [3]. Since the introduc-
tion of β-lactam antibiotics, the spread of methicillin-
resistant S. aureus (MRSA) has increased on a global
scale [4, 5].
Data regarding the prevalence and distribution of
methicillin-sensitive S. aureus (MSSA) and MRSA in
Africa are scarce, and control measures within health-
care settings are limited due to constraints with re-
spect to resources and diagnostic facilities [6]. Studies
on S. aureus carriage by hospital patients in
Madagascar report a MRSA prevalence of between 4
and 13 % [7–11]. The prevalence of S. aureus nasal
carriage in outpatients was 38, and 15 % of cases
were MRSA [7]. Madagascan hospitals set no guide-
lines for screening patients or HCW for MRSA.
Different MRSA strains have emerged in hospitals and
in the community in both Europe and the USA [12, 13].
Factors such as travel and close contact with animals
may contribute to the dissemination of the bacterium in
Africa: one MRSA clone in particular (ST-88-MRSA),
which is found worldwide, is also widespread in West,
Central, and East Africa [14]. A multicentre study con-
ducted across five different African countries identified
one major clone, which is also predominant in
Madagascar (ST-88 IV, spa type t186) [15]. A high
prevalence of the staphylococcal virulence factor,
Panton-Valentine leukocidin (PVL), was found in MSSA
strains isolated from hospital patients from mainland
Africa and the Western Indian Ocean region [8, 16, 17].
Evidence suggests that PVL is associated with staphylo-
coccal skin and soft tissue infections [18]. No data are
available on the presence of PVL in MSSA and MRSA
isolates obtained from HCW in Madagascar. Another
staphylococcal virulence factor, toxic shock syndrome
toxin-1 (TSST-1), causes severe illness and multisystem
clinical manifestations [19]. Few studies report the
prevalence of TSST-1 in healthy carriers from Africa; to
date, no data are available with respect to Madagascan
HCW [20, 21]. Resistance to β-lactam antibiotics (as in
MRSA) is due to the acquisition of the mecA gene. In re-
cent years, a similar gene termed mecC has been de-
scribed, which is often not detected by routine
laboratory tests because standard molecular methods
usually focus only on detecting mecA [22].
Here, we obtained nasal swabs from HCW from differ-
ent hospitals and from healthy non-medical students at
the University of Antananarivo. The aim was to identify
the prevalence and local clonal epidemiology of S. aur-
eus and MRSA in Madagascar.
Methods
Study design
This cross sectional study enrolled non-medical students
from the University of Antananarivo and HCW from five
different hospitals (University Children’s Hospital, the
surgery department at the University Gynaecological
Hospital, the University Infectious Diseases department,
a military hospital, and a private clinic for general and
trauma surgery) and one dispensary in Antananarivo,
Madagascar. HCW were defined according to the WHO
definition [23], which included all study participants
working in a hospital. Hospital staff were informed and
recruited during in-house training sessions, while uni-
versity students were asked to participate during semi-
nars and lectures.
Sample size calculation
The required sample size to yield at least k = 5 MRSA
isolates with about 90 % probability was estimated by as-
suming that the proportion of MRSA among S. aureus
isolates was 5 %, and that 35 % of all sampled individuals








the required minimum sample size was estimated at
526 per arm (HCW and non-medical university
students).
Data and sample collection procedures
After providing informed consent, demographic data
(e.g., sex, age, home community) was collected via a
questionnaire. Students were asked to name their fac-
ulty, and hospital employees were asked to describe their
role and whether their work included regular contact
with patients. Respondents were also asked about hos-
pital admissions within the last 6 months, their history
of antimicrobial treatment within the last 6 months,
whether they lived in a student/healthcare staff hall,
whether they nursed chronically ill relatives at home,
whether they suffer from a chronic illness, and whether
they had any acute skin diseases such as atopic derma-
titis, psoriasis or chronic ulcers. As S. aureus colonises
pets and livestock, the participants were asked whether
they had contact with animals [14]. After the partici-
pants filled in the questionnaire, they were instructed on
how to collect a self-administered nasal swab.
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Microbiological examination of nasal swabs in
Madagascar
The study team demonstrated the technique used to ob-
tain nasal samples using a sterile cotton-tipped swab
(Copan Nasal Swab Transsystem®, Brescia, Italy) and
provided assistance where necessary. The samples were
then immediately transported to the study laboratory
where bacteria were isolated as described below.
After incubation on Columbia blood agar (OXOID®,
Vienna, Austria) for 18–24 h at 35–37 °C, the first step
of the identification procedure involved examination of
colony morphology and Gram staining. Suspected S.
aureus colonies on the blood agar plate were tested for
catalase and coagulase activity, and for latex agglutin-
ation (Staphytec plus, OXOID®) [24]. S. aureus strains
were tested for antibiotic susceptibility using the stand-
ard disc diffusion method on Mueller-Hinton Agar, ac-
cording to current CLSI (Clinical and Laboratory
Standards Institute) guidelines. Antibiotic susceptibility
testing was done for the following locally available and
prescribed antibiotics: penicillin, erythromycin, clinda-
mycin, cotrimoxazole, and ampicillin/sulbactam. Cefoxi-
tin was used as an MRSA screening agent.
S. aureus ATCC-25923, BAA 9176, and methicillin-
resistant S. aureus ATCC-43300 were used as controls.
S. aureus isolates were stored at −80 °C in Cryobank
tubes (Cryobank, MAST®, Liverpool, UK) until shipment
at -20 °C to the Bernhard Nocht Institute for Tropical
Medicine, Germany, for molecular analyses. The
QIAamp DNA Mini Kit (Qiagen®, Hilden, Germany) was
used to extract DNA from all S. aureus isolates, accord-
ing to the manufacturer’s instructions.
Multiplex PCR to confirm S. aureus isolates
In Germany, all S. aureus isolates were further screened
for S. aureus-specific (nuc), MRSA-specific (both mecA
and mecC), and PVL and TSST-1 virulence genes by
multiplex PCR. The primers used are listed in Additional
file 1: Supporting Information Table S1.
PCR was performed using the Qiagen® multiplex PCR
kit (ref. no.-201643). Only strains harbouring the mecA
or mecC genes were classified as MRSA [25].
Staphylococcus protein A gene (spa) typing of MRSA isolates
To examine the clonal epidemiology of MRSA, all PCR-
confirmed MRSA isolates were subjected to spa typing
using the RidomStaphType standard protocol, followed
by double-strand sequencing [26]. Sequences were ana-
lysed using RidomStaphType version 2.2.1 software
(Ridom Ltd., Würzburg, Germany). Associated multi-
locus sequence types (MLST) were automatically
allocated by the Ridom SpaServer according to the based-
upon-repeat-pattern (BURP) algorithm (if sufficient data
were available) [27], or retrieved from the literature.
Treatment of MRSA-positive individuals
If the nasal swabs tested positive for MRSA in
Madagascar, the participant was offered treatment with
Mupirocin (Turixin®) ointment to eradicate the nasal
MRSA (treatment followed the guidelines set down by
the Robert-Koch-Institute, Germany) [28]. After treat-
ment, further nasal swabs were taken to confirm suc-
cessful decolonisation.
Statistical analyses
Pearson’s χ2 test or Fisher’s exact test was used to compare
the frequency distribution of S. aureus and MRSA nasal
carriage by HCW and non-medical students. Age, sex, oc-
cupation, and previous antimicrobial use were variables
entered into a multivariable logistic regression model to
assess their adjusted association with S. aureus carriage.
Analyses were performed using Stata 12 (StataCorp LP,
College Station, USA) software.
Results
Nasal swabs were taken from 863 HCW and 685 stu-
dents. S. aureus was identified in 171 isolates (11.0 %),
of which 20 (1.3 %) were MRSA (Fig. 1).
The point prevalence of nasal S. aureus carriage was
91 (10.4 %) in the HCW group and 80 (11.4 %) in the
student group. MRSA carriage was slightly higher in the
HCW group (1.5 %) than in the student group (0.9 %).
Of the MSSA isolates, 7.3 % were susceptible to peni-
cillin (Table 1). Erythromycin-induced resistance to clin-








































































Fig. 1 Examination procedure for nasal swabs obtained from
university students and healthcare workers. In a first step S.aureus
were identified via PCR-screening for nuc genes and in a second
step these S.aureus were screened for mecA and mecC genes allow-
ing to differentiate between methicillin-resistant and methicillin-
sensitive Staphylococcus aureus
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The prevalence of MRSA carriage was equal among
groups of the same age, and increased with age (Table 2).
Overall, nasal carriage of S. aureus was more common
in women (12.7 %) than in men (8.0 %). Carriage of S.
aureus and MRSA was slightly higher in HCW that re-
ported direct patient contact (Table 3). S. aureus and
MRSA carriage stratified according to medical profes-
sion or workplace is shown in Table 3. There was no
strong association between MRSA carriage and other
risk factors (Tables 4 and 5). Multivariable logistic re-
gression analyses identified female gender and age >
25 years as significantly associated with nasal carriage of
S. aureus (p = 0.003 and p = 0.04, respectively) (Table 6).
In total, 21 S. aureus isolates (11.7 %) harboured PVL
and 36 (21.1 %) harboured TSST-1. Ten (1.2 %) HCW
and 11 (1.6 %) students carried PVL-positive strains in
the anterior nares, while 20 HCW (2.3 %) and 16 (1.9 %)
students carried TSST-1-positive strains (Table 7).
Recent findings indicate global occurrence of a new di-
vergent mecA homologue, named mecC [29]; therefore,
all samples were also screened for the mecC gene. All
MRSA isolates identified in this study harboured the
mecA gene, but not the mecC gene.
Staphylococcus protein A gene (spa) typing was per-
formed for all 20 MRSA isolates. Of the five different spa
types identified, spa type t186 was the predominant clone
(16/20, 80.0 %) among both HCW and students (Table 7).
The associated sequence type (ST) for spa types t186 and
t2393 was ST-88. Eighteen MRSA-positive participants
were treated with Mupirocin and were successfully deco-
lonised. In accordance with the current guidelines of the
Robert-Koch-Institute, Germany, one HCW required re-
peated Mupirocin treatment to ensure eradication [28].
Table 1 Antibiotic susceptibility of methicillin-sensitive and
methicillin-resistant Staphylococcus aureus
Susceptibility [Frequency (%)]
Drug (ACa μg) MSSAb (N = 151) MRSAc (N = 20)
Cefoxitin (30) 151 (100) 0 0
Clindamycin (2) 149 (98.7) 20 (100)
Cotrimoxazole (30) 142 (94.0) 17 (85.0)
Erythromycin (15) 114 (75.5) 12 (60.0)




Table 2 Prevalence of Staphylococcus aureus (S. aureus) and methicillin-sensitive (MSSA) and methicillin-resistant Staphylococcus aureus
(MRSA) in healthcare workers and students in Antananarivo, Madagascar (N = 1548)
Healthcare workersa Students
S. aureus MSSA MRSA S. aureus MSSA MRSA
Total number (N) n (%) n (%) pb n (%) pb Total number (N) n (%) n (%) pb n (%) pb
Prevalence 863 91 (10.4) 77 (8.9) – 14 (1.5) – 685 80 (11.8) 74 (10.8) – 6 (0.9) –
Characteristics
Age
<25 years 403 33 (8.2) 29 (7.2) 0.11 4 (1.0) 0.19* 603 70 (11.5) 65 (10.8) 0.80 5 (0.7) 0.52*
≥25 years 452 56 (12.4) 46 (10.2) 10 (2.1) 78 10 (12.7) 9 (11.4) 1 (1.3)
Sex
Female 580 72 (12.3) 60 (10.2) 0.04 12 (2.1) 0.16* 440 57 (12.6) 52 (11.7) 0.24 5 (1.0) 0.43*
Male 283 19 (6.6) 17 (5.1) 2 (0.7) 245 23 (9.4) 22 (9.0) 1 (0.3)
aIncludes all hospital employees (medical doctors, nurses, midwives, nursing students, medical and pharmacy students, interns, occasional workers, medical
technologists, pharmacists, cleaning staff, and receptionists)
bPearson’s χ2 test or * Fisher’s exact test
Table 3 Descriptive characteristics of healthcare workers
from Antananarivo, Madagascar carrying Staphylococcus
aureus (S. aureus) and methicillin-resistant Staphylococcus
aureus (MRSA)
Healthcare workersa (n = 863)
S. aureus MRSA
Variable HCWb group (n) n (%) n (%)
Contact with patients 746 81 (10.9) 14 (1.9)
No contact with patients 105 7 (6.7) 0
Type of healthcare workerc
Physician 183 13 (7.1) 1 (0.6)
Nurse 203 23 (11.2) 4 (2.0)
Medical technologist 18 3 (16.7) 2 (11.1)
Other (clerk, service assistant) 9 1 (11.0) 0
Work placec
Outpatient department 5 3 (60.0) 0
Operating theatre 6 1 (16.7) 0
Ward 87 11 (12.5) 2 (2.3)
Other (administration) 52 2 (3.9) 0
a Includes all hospital employees: medical doctors, nurses, midwives, nursing
students, medical and pharmacy students, interns, occasional workers, medical
technologists, pharmacists, cleaning staff, and receptionists
b Healthcare worker
c For available data
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Discussion
To the best of our knowledge, this is the first study to
report nasal S. aureus and MRSA carriage rates in HCW
and non-medical university students in Madagascar. The
overall prevalence of nasal S. aureus carriage identified
in this study is lower than that reported in another study
from Madagascar, which identified MSSA in 38 % of
outpatients [7].
The finding that nasal carriage of S. aureus is higher in
females is in line with a study of HCW from Norway,
which showed that female HCW had a 54 % increased
risk of S. aureus nasal carriage versus non-HCW (OR,
1.54; 95 % CI, 1.09–2.19). However, the Norwegian study
differed from the current study in terms of both study
design and detection methods used [30].
Data regarding nasal carriage of MRSA by African
HCW are scarce. Studies of HCW from Ethiopia and
Libya identified nasal carriage rates for MRSA of 14.1 %
[31] and 36.8 % [32]), respectively, whereas a study from
Kenya found a nasal carriage rate of 0 % [33]. A study
from São Tomé and Principe sampled HCW at two dif-
ferent time points and found that the MRSA prevalence
ranged from 1.6 to 4.0 % [34]. A systematic review of
MRSA carriage by HCW in non-outbreak situations in
Europe and the USA calculated a pooled MRSA colon-
isation rate of 1.8 % (95 % CI, 1.34–2.50 %) [35]. Car-
riage rates identified by the individual studies in this
particular review ranged from 0.2 to 15 %. Taken to-
gether, these studies show that MRSA carriage rates in
HCW are highly variable.
PVL is a cytotoxin that causes dermonecrosis and lysis
of human granulocytes and increases the adherence of S.
aureus to the extracellular matrix [36]. Evidence suggests
that PVL is associated with staphylococcal skin and soft
tissue infections and with severe necrotising pneumonia
[18]. As MRSA-colonised HCW may act as a source of
infection in outbreak settings [3], we sought to identify
this virulence factor in all S. aureus isolates. Previous
studies from Africa reported high rates for PVL in
MSSA strains (ranging from 17 to 74 %) [8, 16]. A study
from Gabon reported high PVL rates in both clinical iso-
lates (54.7 %) and isolates obtained from asymptomatic
carriers (40.5 %) [21]. Finally, a study by Breurec et al.
found that 30 % of clinical isolates from Antananarivo
were PVL-positive [8]. The comparatively moderate
PVL-positivity rate (11.6 %) identified in our study is in
Table 4 Descriptive characteristics of healthcare workers from Antananarivo, Madagascar, with respect to carriage of Staphylococcus
aureus (S. aureus) and methicillin-resistant Staphylococcus aureus (MRSA)
Healthcare workersa (n = 863)
S. aureus MRSA
Variables Total number (Nb) HCWc group (n)b n (%) pd n (%) pd
Previous hospitalisation 47 37 1 (2.7) 0.17* 0 1.0*
No previous hospitalisations 1479 816 89 (10.8) 14 (1.7)
Previous antimicrobial usee 493 310 27 (8.7) 0.18 4 (1.3) 0.59*
No previous antimicrobial use 919 506 59 (11.7) 10 (2.0)
Unknown 108
Skin infection 214 121 15 (12.4) 0.47 3 (2.5) 0.44*
No skin infection 1300 724 74 (10.2) 11 (1.5)
Chronic illnessf 119 68 9 (13.1) 0.44 0 0.62*
No chronic illness 1358 772 79 (10.2) 14 (1.8)
Nursing at homeg 486 403 41 (10.2) 0.73 7 (1.7 0.84
No nursing at home 1025 449 49 (10.9) 7 (1.6)
Living in dormatory 190 94 7 (7.5) 0.30 0 (1.1) 0.37*
Not living in dormatory 1306 757 82 (10.8) 14 (2.7)
Contact with animals h 764 417 41 (9.8) 0.50 7 (1.7) 0.90
No contact with animals 784 446 50 (11.2) 7 (1.6)
a Includes all hospital employees: medical doctors, nurses, midwives, nursing students, medical and pharmacy students, interns, occasional workers, medical
technologists, pharmacists, cleaning staff, and receptionists
b For available data
c Healthcare worker
d Pearson’s χ2 test or * Fishers exact test
eDuring the last 6 months
f Chronic illness affecting the immune system
g Nursing sick family members at home
h Contact with pets and/or livestock such as cattle, poultry, pigs, sheep and goats
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contrast with that found in industrialised countries, in
which PVL is rare; however, our findings support those
of previous studies from sub-Saharan Africa [8, 16, 21].
A recent study from Congo identified the TSST-1-
encoding gene in 17.5 % of all S. aureus isolates obtained
from HCW [20]. We found even higher rates in both
groups examined herein, suggesting that TSST-1 may be
more prevalent in S. aureus strains from Africa than in
strains from Europe, making infection control practices
in Malagasy hospitals an urgent priority.
MRSA spa type t186 was the predominant clone identi-
fied in the current cohort, and the most common type
identified in HCW. Spa type t186 was one of the clones
previously circulating in hospital patients in Antananarivo,
Madagascar [15]. According to the RidomSpa Server data-
base [26], this clone occurs worldwide, and the automatic-
ally allocated sequence type ST-88 [27] is predominant in
West, Central and East Africa [14]. The spa type t2393
identified herein was also identified in hospital isolates
from Ghana, north-eastern Argentina and from a patient
from Berlin with a travel history to Panama, whereas spa
type t5562 was found in New Zealand isolates [37–40].
Limitations
A lack of selective enrichment before culture on agar
plates may explain the low prevalence of S. aureus detec-
tion. Also, S. aureus frequently colonises other sites on
the skin, which were not swabbed in this study due to
ethical and operational reasons [41]. This may also ac-
count for the low rate of S. aureus detection.
Table 5 Descriptive characteristics of students from Antananarivo, Madagascar, with respect to carriage of Staphylococcus
aureus (S. aureus) and methicillin-resistant Staphylococcus aureus (MRSA)
Students (n = 685)
S. aureus MRSA
Variables Total number (Na) Student group (n)a n (%) pb n (%) pb
Previous hospitalisation 47 10 2 (20.0) 0.34* 0 1.0*
No previous hospitalisations 1479 663 78 (11.9) 6 (0.9)
Previous antimicrobial usec 493 183 19 (10.4) 0.99 1 (0.6) 1.0*
No previous antimicrobial use 919 413 43 (10.4) 4 (1.0)
Unknown 108
Skin infection 214 93 5 (5.4) 0.04* 0 1.0*
No skin infection 1300 576 75 (13.0) 6 (1.0)
Chronic illnessd 119 51 8 (15.7) 0.37 0 1.0*
No chronic illness 1358 586 67 (11.3) 4 (0.7)
Nursing at homee 486 83 9 (10.8) 0.77 0 1.0*
No nursing at home 1025 576 69 (12.0) 6 (1.0)
Living in dormatory 190 96 8 (8.2) 0.28 0 0.60*
Not living in dormatory 1306 549 67 (12.2) 6 (1.1)
Contact with animals f 764 347 41 (11.8) 0.91 2 (0.6) 0.43*
No contact with animals 784 338 39 (11.4) 4 (1.2)
aFor available data
b Pearson’s χ2 test or * Fishers exact test
cDuring the last 6 months
d Chronic illness affecting the immune system
e Nursing sick family members at home
f Contact with pets and/or livestock such as cattle, poultry, pigs, sheep and goats
Table 6 Multivariable logistic regression analyses of factors
associated with nasal colonisation of healthcare workers and
university students by Staphylococcus aureus
Variable Category n ORa (95 % CIb) p
Age
Age <25 (years) 403 1
Age >25 (years) 452 1.47 (1.02–2.13) 0.04
Sex
Female 580 1
Male 283 0.57 (0.40–0.83) 0.003
Occupation
Student 685 1
Healthcare worker 863 0.77 (0.54–1.11) 0.16
Antibioticsc
No previous antimicrobial use 919 1
Previous antimicrobial use 493 1.17 (0.91–1.49) 0.22
aOR, odds ratio, adjusted according to multivariable logistic regression
bCI, confidence interval
cDuring the last 6 months
Hogan et al. BMC Infectious Diseases  (2016) 16:420 Page 6 of 9
The samples examined herein were collected by self-
administered nasal swabbing; therefore, sampling may
have not been carried out in the best possible way. How-
ever, other large, population-based studies of MRSA car-
riage in Europe were based on self-swabbing techniques,
and nasal self-swabbing itself has been shown to be appro-
priate for the detection of S. aureus and MRSA [42–44].
A large part of our study population consisted of stu-
dents; therefore, we may expect a lower prevalence of S.
aureus in such healthy participants compared with that
in outpatients or hospitalised patients.
It was our intention not to include high-risk groups
such as children or people over the age of 69 years, and
a group of healthy and relatively young students was
used as a proxy for community controls. The relatively
low number of S. aureus and MRSA isolates mean that
the present study has low statistical power; therefore, we
may not have detected any association between colonisa-
tion and risk factors such as skin lesions [3].
Conclusion
In conclusion, this study provides a good overview of
MRSA clones circulating in this particular region of
Madagascar. The prevalence of MRSA in HCW and
healthy students from Madagascar was low, and all S. aur-
eus strains showed high resistance to penicillin, which is in
line with other reports across the African continent. Spa
type t186, which is the dominant clone on mainland Africa,
was also the predominant MRSA clone identified in the
current study population. The fairly high rates of TSST-1
and the presence of PVL-producing strains represent a po-
tential reservoir and source for possible severe infection,
which could lead to the emergence of successful MRSA
clones. From a clinical point-of-view, MRSA screening
programs in Africa are limited by a lack of facilities and a
lack of qualified staff and financial resources. Antibiotic
regimens to eradicate MRSA are expensive. However, gen-
eral hygiene measures (e.g., hand washing) are both cheap
and effective at preventing the spread of MRSA by HCW
and should be promoted and performed diligently.
Additional file
Additional file 1: Supporting Information Table S1. Primers used for
PCR screening of nasal S. aureus isolates obtained from Madagascan
students and healthcare workers. (PDF 73 kb)
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Table 7 Molecular epidemiology of methicillin-resistant
Staphylococcus aureus isolated from students and healthcare
workers from Antananarivo (n = 20)








88f 88g t186 0 1 12 4
88g 88g t2393 0 0 0 1
n.dh n.dh t5562 0 0 0 1
n.dh n.dh t5772 0 0 1 0




d Panton-Valentine leukocidin gene present
e Toxic shock syndrome toxin gene present
f Automatically allocated by the Ridom SpaServer [25]
g Retrieved from the literature [37]
h Not determined
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